We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Inactivated Recombinant Rabies Virus Displaying the Nipah Virus Envelope Glycoproteins Induces Systemic Immune Responses in Mice.
- Authors
Li, Zhengrong; Zhu, Yanting; Yan, Feihu; Jin, Hongli; Wang, Qi; Zhao, Yongkun; Feng, Na; Wang, Tiecheng; Li, Nan; Yang, Songtao; Xia, Xianzhu; Cong, Yanlong
- Abstract
Nipah virus (NiV) causes severe, lethal encephalitis in humans and pigs. However, there is no licensed vaccine available to prevent NiV infection. In this study, we used the reverse genetic system based on the attenuated rabies virus strain SRV9 to construct two recombinant viruses, rSRV9-NiV-F and rSRV9-NiV-G, which displayed the NiV envelope glycoproteins F and G, respectively. Following three immunizations in BALB/c mice, the inactivated rSRV9-NiV-F and rSRV9-NiV-G alone or in combination, mixed with the adjuvants ISA 201 VG and poly (I:C), were able to induce the antigen-specific cellular and Th1-biased humoral immune responses. The specific antibodies against rSRV9-NiV-F and rSRV9-NiV-G had reactivity with two constructed bacterial-like particles displaying the F and G antigens of NiV. These data demonstrate that rSRV9-NiV-F or rSRV9-NiV-G has the potential to be developed into a promising vaccine candidate against NiV infection.
- Subjects
NIPAH virus; RABIES virus; RECOMBINANT viruses; GLYCOPROTEINS; IMMUNE response
- Publication
Vaccines, 2023, Vol 11, Issue 12, p1758
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines11121758